Literature DB >> 27993850

Pharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin.

Michail S Lionakis1, Nathaniel D Albert2, Muthulekha Swamydas3, Chyi-Chia R Lee4, Pius Loetscher5, Dimitrios P Kontoyiannis6.   

Abstract

Systemic candidiasis is a leading cause of nosocomial bloodstream infection with a high mortality rate despite treatment. Immune-based strategies are needed to improve outcomes. We previously reported that genetic deficiency in the chemokine receptor CCR1 improves survival and ameliorates tissue damage in Candida-infected mice. Here, we found that treatment of immunocompetent Candida-infected mice with the CCR1-selective antagonist BL5923 improves survival, decreases the kidney fungal burden, and protects from renal tissue injury.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CCR1; Candida; candidiasis; chemokine receptor

Mesh:

Substances:

Year:  2017        PMID: 27993850      PMCID: PMC5328547          DOI: 10.1128/AAC.02365-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Invasive Candidiasis.

Authors:  Bart Jan Kullberg; Maiken C Arendrup
Journal:  N Engl J Med       Date:  2015-10-08       Impact factor: 91.245

2.  An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis.

Authors:  L Romani; A Mencacci; E Cenci; G Del Sero; F Bistoni; P Puccetti
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

3.  The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.

Authors:  Emily Wang; Dimitrios Farmakiotis; Daisy Yang; Deborah A McCue; Hagop M Kantarjian; Dimitrios P Kontoyiannis; Michael S Mathisen
Journal:  J Antimicrob Chemother       Date:  2015-04-07       Impact factor: 5.790

4.  CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.

Authors:  Alexandre Bignon; Françoise Gaudin; Patrice Hémon; Hugo Tharinger; Katia Mayol; Thierry Walzer; Pius Loetscher; Michel Peuchmaur; Dominique Berrebi; Karl Balabanian
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

Review 5.  Invasive Candidiasis.

Authors:  Todd P McCarty; Peter G Pappas
Journal:  Infect Dis Clin North Am       Date:  2015-12-29       Impact factor: 5.982

6.  The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.

Authors:  Volha Ninichuk; Alexander G Khandoga; Stephan Segerer; Pius Loetscher; Achim Schlapbach; Laszlo Revesz; Roland Feifel; Andrej Khandoga; Fritz Krombach; Peter J Nelson; Detlef Schlöndorff; Hans-Joachim Anders
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

7.  Candida-associated renal papillary necrosis.

Authors:  J F Tomashefski; C R Abramowsky
Journal:  Am J Clin Pathol       Date:  1981-02       Impact factor: 2.493

8.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

Review 9.  New insights into innate immune control of systemic candidiasis.

Authors:  Michail S Lionakis
Journal:  Med Mycol       Date:  2014-07-14       Impact factor: 4.076

10.  Candida and host determinants of susceptibility to invasive candidiasis.

Authors:  Michail S Lionakis; Mihai G Netea
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

View more
  6 in total

1.  The role of neutrophils in host defense against invasive fungal infections.

Authors:  Jigar V Desai; Michail S Lionakis
Journal:  Curr Clin Microbiol Rep       Date:  2018-06-22

Review 2.  Local antifungal immunity in the kidney in disseminated candidiasis.

Authors:  Chetan V Jawale; Partha S Biswas
Journal:  Curr Opin Microbiol       Date:  2021-05-12       Impact factor: 7.584

3.  Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicans Infection.

Authors:  Marcin Stawowczyk; Shamoon Naseem; Valeria Montoya; Darren P Baker; James Konopka; Nancy C Reich
Journal:  MBio       Date:  2018-04-17       Impact factor: 7.867

4.  Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection.

Authors:  Marc Swidergall; Mina Khalaji; Norma V Solis; David L Moyes; Rebecca A Drummond; Bernhard Hube; Michail S Lionakis; Craig Murdoch; Scott G Filler; Julian R Naglik
Journal:  J Infect Dis       Date:  2019-09-26       Impact factor: 5.226

Review 5.  Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma.

Authors:  Annette Gilchrist; Stephanie L Echeverria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-25       Impact factor: 5.555

Review 6.  The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future.

Authors:  Gloria Hoi Wan Tso; Jose Antonio Reales-Calderon; Norman Pavelka
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.